KIMBERLY SIRK: Open Payments
NPI 1114281466 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,264 in 97 payments from 20 companies in 2025. Trend: 2023 $3,670 · 2024 $3,637 · 2025 $2,264
Food & beverage: $2,264
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $428 |
| ABBVIE INC. | 20 | $337 |
| Neurocrine BioSciences, Inc. | 11 | $289 |
| E.R. Squibb & Sons, L.L.C. | 7 | $175 |
| Axsome Therapeutics, Inc. | 7 | $162 |
| Tris Pharma Inc | 8 | $150 |
| Corium, LLC | 6 | $124 |
| Otsuka America Pharmaceutical, Inc. | 5 | $113 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $83 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
Products named: FANAPT, VRAYLAR, INGREZZA, COBENFY, REXULTI, Dyanavel XR, Azstarys, Sunosi.
Industry payments across IN — which companies pay providers there.
